Nutrients mediate intestinal bacteria-mucosal immune crosstalk

Frontiers in Immunology

Volumn 9, Issue JAN, 2018, Pages

  Ma, Ning ^a   Guo, Pingting ^a   Zhang, Jie ^a,b   He, Ting ^a   Kim, Sung Woo ^c   Zhang, Guolong ^d   Ma, Xi ^a,e  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING VOCATIONAL COLLEGE OF AGRICULTURE   (China)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d OKLAHOMA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bacteria; Crosstalk; Intestine; Mucosal immunity; nutrients

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; KYNURENINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PEPTIDOGLYCAN; POLYSACCHARIDE; SEROTONIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TRYPTOPHAN;

ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; CELL DIFFERENTIATION; ENTEROBACTERIACEAE; FAT INTAKE; HELICOBACTER PYLORI; HYDROLYSIS; IMMUNE SYSTEM; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; KLEBSIELLA; MICROBIAL COMMUNITY; MUCOSA; NONHUMAN; NUTRITION; OBESITY; OLIGOMERIZATION; PROTEIN METABOLISM; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STREPTOCOCCUS;

EID: 85041069011     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00005     Document Type: Review

References (150)

1. Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol (2013) 28(Suppl 4):9-17. doi:10.1111/jgh.12294
2. Defendenti C, Atzeni F, Malandrin S, Ardizzone S, Almasio PL, Saibeni S, et al. Anti-tumour necrosis factor-alpha antibodies and B cell homeostasis in human inflammatory bowel diseases. Int Immunopharmacol (2018) 54:329-35. doi:10.1016/j.intimp.2017.11.016
3. Schuster M, Sexton DJ, Diggle SP, Greenberg EP. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu Rev Microbiol (2013) 67:43-63. doi:10.1146/annurev-micro-092412-155635
4. Blottiere HM, de Vos WM, Ehrlich SD, Dore J. Human intestinal metagenomics: state of the art and future. Curr Opin Microbiol (2013) 16(3):232-9. doi:10.1016/j.mib.2013.06.006
5. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol (2016) 16(6):341-52. doi:10.1038/nri.2016.42
6. Wang Q, Westra J, van der Geest KS, Moser J, Bijzet J, Kuiper T, et al. Reduced levels of cytosolic DNA sensor AIM2 are associated with impaired cytokine responses in healthy elderly. Exp Gerontol (2016) 78:39-46. doi:10.1016/j.exger.2016.02.016
7. Reynolds JM, Pappu BP, Peng J, Martinez GJ, Zhang Y, Chung Y, et al. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity (2010) 32(5):692-702. doi:10.1016/j.immuni.2010.04.010
8. Gutzeit C, Magri G, Cerutti A. Intestinal IgA production and its role in host-microbe interaction. Immunol Rev (2014) 260(1):76-85. doi:10.1111/imr.12189
9. Birchenough G, Hansson GC. Bacteria tell us how to protect our intestine. Cell Host Microbe (2017) 22(1):3-4. doi:10.1016/j.chom.2017.06.011
10. Johansson ME, Jakobsson HE, Holmen-Larsson J, Schutte A, Ermund A, Rodriguez-Pineiro AM, et al. Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe (2015) 18(5):582-92. doi:10.1016/j.chom.2015.10.007
11. Hernandez-Chirlaque C, Aranda CJ, Ocon B, Capitan-Canadas F, Ortega-Gonzalez M, Carrero JJ, et al. Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis. J Crohns Colitis (2016) 10(11):1324-35. doi:10.1093/ecco-jcc/jjw096
12. Kozakova H, Schwarzer M, Tuckova L, Srutkova D, Czarnowska E, Rosiak I, et al. Colonization of germ-free mice with a mixture of three Lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell Mol Immunol (2016) 13(2):251-62. doi:10.1038/cmi.2015.09
13. Arike L, Holmen-Larsson J, Hansson GC. Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. Glycobiology (2017) 27(4):318-28. doi:10.1093/glycob/cww134
14. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut (2013) 62(10):1505-10. doi:10.1136/gutjnl-2012-303954
15. Macpherson AJ, de Aguero MG, Ganal-Vonarburg SC. How nutrition and the maternal microbiota shape the neonatal immune system. Nat Rev Immunol (2017) 17(8):508-17. doi:10.1038/nri.2017.58
16. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep (2006) 7(7):688-93. doi:10.1038/sj.embor.7400731
17. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 104(34):13780-5. doi:10.1073/pnas.0706625104
18. Castaneda FE, Walia B, Vijay-Kumar M, Patel NR, Roser S, Kolachala VL, et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology (2005) 129(6):1991-2008. doi:10.1053/j.gastro.2005.09.017
19. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One (2012) 7(9):e44328. doi:10.1371/journal.pone.0044328
20. Ortega-Cava CF, Ishihara S, Rumi MA, Aziz MM, Kazumori H, Yuki T, et al. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol (2006) 13(1):132-8. doi:10.1128/cvi.13.1.132-138.2006
21. Spiljar M, Merkler D, Trajkovski M. The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front Immunol (2017) 8:1353. doi:10.3389/fimmu.2017.01353
22. Frosali S, Pagliari D. How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology. J Immunol Res (2015) 2015:489821. doi:10.1155/2015/489821
23. Dheer R, Santaolalla R, Davies JM, Lang JK, Phillips MC, Pastorini C, et al. Intestinal epithelial toll-like receptor 4 signaling affects epithelial function and colonic microbiota and promotes a risk for transmissible colitis. Infect Immun (2016) 84(3):798-810. doi:10.1128/IAI.01374-15
24. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 10(2):131-44. doi:10.1038/nri2707
25. Fukata M, Abreu MT. TLR4 signalling in the intestine in health and disease. Biochem Soc Trans (2007) 35(Pt 6):1473-8. doi:10.1042/BST0351473
26. Fitzgerald KA, Rowe DC, Golenbock DT. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect (2004) 6(15):1361-7. doi:10.1016/j.micinf.2004.08.015
27. Mancuso G, Midiri A, Biondo C, Beninati C, Gambuzza M, Macri D, et al. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4. Infect Immun (2005) 73(9):5620-7. doi:10.1128/IAI.73.9.5620-5627.2005
28. Wang Y, Devkota S, Musch MW, Jabri B, Nagler C, Antonopoulos DA, et al. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One (2010) 5(10):e13607. doi:10.1371/journal.pone.0013607
29. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol (2002) 37(9):1034-41. doi:10.1080/003655202320378220
30. Gerova VA, Stoynov SG, Katsarov DS, Svinarov DA. Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test. World J Gastroenterol (2011) 17(17):2211-5. doi:10.3748/wjg.v17.i17
31. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A (2008) 105(52):20858-63. doi:10.1073/pnas.0808723105
32. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science (2011) 334(6053):255-8. doi:10.1126/science.1209791
33. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science (2010) 328(5975):228-31. doi:10.1126/science.1179721
34. Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology (2014) 147(6):1363-77.e17. doi:10.1053/j.gastro.2014.08.033
35. Carvalho FA, Aitken JD, Vijay-Kumar M, Gewirtz AT. Toll-like receptor-gut microbiota interactions: perturb at your own risk! Annu Rev Physiol (2012) 74:177-98. doi:10.1146/annurev-physiol-020911-153330
36. Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe (2012) 12(2):139-52. doi:10.1016/j.chom.2012.07.004
37. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut (2014) 63(7):1069-80. doi:10.1136/gutjnl-2013-304909
38. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest (2007) 117(12):3909-21. doi:10.1172/jci33084
39. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 9(12):e1001212. doi:10.1371/journal.pbio.1001212
40. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 145(5):745-57. doi:10.1016/j.cell.2011.04.022
41. Claes AK, Zhou JY, Philpott DJ. NOD-like receptors: guardians of intestinal mucosal barriers. Physiology (2015) 30(3):241-50. doi:10.1152/physiol.00025.2014
42. Robertson SJ, Zhou JY, Geddes K, Rubino SJ, Cho JH, Girardin SE, et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes (2013) 4(3):222-31. doi:10.4161/gmic.24373
43. Kim D, Kim YG, Seo SU, Kim DJ, Kamada N, Prescott D, et al. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin. Nat Med (2016) 22(5):524-30. doi:10.1038/nm.4075
44. Rauch I, Deets KA, Ji DX, von Moltke J, Tenthorey JL, Lee AY, et al. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and-8. Immunity (2017) 46(4):649-59. doi:10.1016/j.immuni.2017.03.016
45. Brubaker SW, Monack DM. Cell-intrinsic defense at the epithelial border wall: salmonella pays the price. Immunity (2017) 46(4):522-4. doi:10.1016/j.immuni.2017.03.021
46. Yao X, Zhang C, Xing Y, Xue G, Zhang Q, Pan F, et al. Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis. Nat Commun (2017) 8(1):1896. doi:10.1038/s41467-017-01917-2
47. Chen L, Wilson JE, Koenigsknecht MJ, Chou WC, Montgomery SA, Truax AD, et al. NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol (2017) 18(5):541-51. doi:10.1038/ni.3690
48. Kanneganti TD. Inflammatory bowel disease and the NLRP3 inflammasome. N Engl J Med (2017) 377(7):694-6. doi:10.1056/NEJMcibr1706536
49. Malik S, Sadhu S, Elesela S, Pandey RP, Chawla AS, Sharma D, et al. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells. Nat Commun (2017) 8(1):815. doi:10.1038/s41467-017-00674-6
50. Negi V, Paul D, Das S, Bajpai P, Singh S, Mukhopadhyay A, et al. Altered expression and editing of miRNA-100 regulates iTreg differentiation. Nucleic Acids Res (2015) 43(16):8057-65. doi:10.1093/nar/gkv752
51. Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell (2015) 163(2):367-80. doi:10.1016/j.cell.2015.08.058
52. Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity (2014) 40(4):594-607. doi:10.1016/j.immuni.2014.03.005
53. Wu W, Liu HP, Chen F, Liu H, Cao AT, Yao S, et al. Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-beta production. Eur J Immunol (2016) 46(5):1162-7. doi:10.1002/eji.201546160
54. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 500(7461):232-6. doi:10.1038/nature12331
55. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2011) 331(6015):337-41. doi:10.1126/science.1198469
56. Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol (2008) 9:65. doi:10.1186/1471-2172-9-65
57. Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes (2015) 6(4):234-42. doi:10.1080/19490976.2015.1056973
58. NeffCP, Rhodes ME, Arnolds KL, Collins CB, Donnelly J, Nusbacher N, et al. Diverse intestinal bacteria contain putative zwitterionic capsular polysaccharides with anti-inflammatory properties. Cell Host Microbe (2016) 20(4):535-47. doi:10.1016/j.chom.2016.09.002
59. Kato LM, Kawamoto S, Maruya M, Fagarasan S. The role of the adaptive immune system in regulation of gut microbiota. Immunol Rev (2014) 260(1):67-75. doi:10.1111/imr.12185
60. Zhao HD, Sun MN, Li MD, Li FL, Li H. Dishevelled-1 (Dvl-1) protein: a potential participant of oxidative stress induced by selenium deficiency. Biol Trace Elem Res (2014) 157(1):45-50. doi:10.1007/s12011-013-9859-5
61. Pongracz J, Hare K, Harman B, Anderson G, Jenkinson EJ. Thymic epithelial cells provide WNT signals to developing thymocytes. Eur J Immunol (2003) 33(7):1949-56. doi:10.1002/eji.200323564
62. Okamura RM, Sigvardsson M, Galceran J, Verbeek S, Clevers H, Grosschedl R. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity (1998) 8(1):11-20. doi:10.1016/S1074-7613(00)80454-9
63. Ding Y, Shen S, Lino AC, Curotto de Lafaille MA, Lafaille JJ. Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat Med (2008) 14(2):162-9. doi:10.1038/nm1707
64. Belinson H, Savage AK, Fadrosh D, Kuo YM, Lin D, Valladares R, et al. Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis. JCI Insight (2016) 1(10):e85395. doi:10.1172/jci.insight.85395
65. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol (2011) 29:273-93. doi:10.1146/annurev-immunol-031210-101317
66. Corthesy B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol (2013) 4:185. doi:10.3389/fimmu.2013.00185
67. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity (2002) 17(1):107-15. doi:10.1016/S1074-7613(02)00341-2
68. Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol (2010) 28:243-73. doi:10.1146/annurev-immunol-030409-101314
69. Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol (2004) 172(5):3026-33. doi:10.4049/jimmunol.172.5.3026
70. Lecuyer E, Rakotobe S, Lengline-Garnier H, Lebreton C, Picard M, Juste C, et al. Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity (2014) 40(4):608-20. doi:10.1016/j.immuni.2014.03.009
71. Moor K, Diard M, Sellin ME, Felmy B, Wotzka SY, Toska A, et al. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature (2017) 544(7651):498-502. doi:10.1038/nature22058
72. Bevins CL, Salzman NH. The potter's wheel: the host's role in sculpting its microbiota. Cell Mol Life Sci (2011) 68(22):3675-85. doi:10.1007/s00018-011-0830-3
73. Mirpuri J, Raetz M, Sturge CR, Wilhelm CL, Benson A, Savani RC, et al. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes (2014) 5(1):28-39. doi:10.4161/gmic.26489
74. Kubinak JL, Petersen C, Stephens WZ, Soto R, Bake E, O'Connell RM, et al. MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe (2015) 17(2):153-63. doi:10.1016/j.chom.2014.12.009
75. Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol (2015) 159(2):122-7. doi:10.1016/j.clim.2015.05.014
76. Ghaffarzadegan T, Zhong Y, Fak Hallenius F, Nyman M. Effects of barley variety, dietary fiber and beta-glucan content on bile acid composition in cecum of rats fed low-and high-fat diets. J Nutr Biochem (2017) 53:104-10. doi:10.1016/j.jnutbio.2017.10.008
77. Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev (2012) 70(Suppl 1):S10-3. doi:10.1111/j.1753-4887.2012.00499.x
78. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell (2016) 167(5):1339. doi:10.1016/j.cell.2016.10.043
79. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun (2015) 6:7320. doi:10.1038/ncomms8320
80. Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun (2015) 6:6734. doi:10.1038/ncomms7734
81. Dore J, Blottiere H. The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol (2015) 32:195-9. doi:10.1016/j.copbio.2015.01.002
82. Chen T, Long W, Zhang C, Liu S, Zhao L, Hamaker BR. Fiber-utilizing capacity varies in Prevotella-versus Bacteroides-dominated gut microbiota. Sci Rep (2017) 7(1):2594. doi:10.1038/s41598-017-02995-4
83. Kiilerich P, Myrmel LS, Fjaere E, Hao Q, Hugenholtz F, Sonne SB, et al. Effect of a long-term high-protein diet on survival, obesity development, and gut microbiota in mice. Am J Physiol Endocrinol Metab (2016) 310(11):E886-99. doi:10.1152/ajpendo.00363.2015
84. Jorgensen BP, Hansen JT, Krych L, Larsen C, Klein AB, Nielsen DS, et al. A possible link between food and mood: dietary impact on gut microbiota and behavior in BALB/c mice. PLoS One (2014) 9(8):e103398. doi:10.1371/journal.pone.0103398
85. Kang SS, Jeraldo PR, Kurti A, Miller ME, Cook MD, Whitlock K, et al. Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener (2014) 9:36. doi:10.1186/1750-1326-9-36
86. Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R, et al. Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience (2015) 300:128-40. doi:10.1016/j.neuroscience.2015.05.016
87. Heinritz SN, Weiss E, Eklund M, Aumiller T, Louis S, Rings A, et al. Intestinal microbiota and microbial metabolites are changed in a pig model fed a high-fat/low-fiber or a low-fat/high-fiber diet. PLoS One (2016) 11(4):e0154329. doi:10.1371/journal.pone.0154329
88. Salonen A, de Vos WM. Impact of diet on human intestinal microbiota and health. Ann Rev Food Sci Technol (2014) 5:239-62. doi:10.1146/annurev-food-030212-182554
89. Ma N, Tian Y, Wu Y, Ma X. Contributions of the interaction between dietary protein and gut microbiota to intestinal health. Curr Protein Pept Sci (2017) 18(8):795-808. doi:10.2174/1389203718666170216153505
90. Dai ZL, Zhang J, Wu G, Zhu WY. Utilization of amino acids by bacteria from the pig small intestine. Amino Acids (2010) 39(5):1201-15. doi:10.1007/s00726-010-0556-9
91. Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, et al. Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res (2013) 68(1):95-107. doi:10.1016/j.phrs.2012.11.005
92. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol (2014) 12(10):661-72. doi:10.1038/nrmicro3344
93. Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L, Calder AG, et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res (2013) 57(3):523-35. doi:10.1002/mnfr.201200594
94. Million M, Diallo A, Raoult D. Gut microbiota and malnutrition. Microb Pathog (2017) 106:127-38. doi:10.1016/j.micpath.2016.02.003
95. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature (2014) 510(7505):417-21. doi:10.1038/nature13421
96. Powell JD, Pollizzi KN, Heikamp EB, Horton MR. Regulation of immune responses by mTOR. Annu Rev Immunol (2012) 30:39-68. doi:10.1146/annurev-immunol-020711-075024
97. Wells JM, Loonen LM, Karczewski JM. The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. Int J Med Microbiol (2010) 300(1):41-8. doi:10.1016/j.ijmm.2009.08.008
98. Kinnebrew MA, Pamer EG. Innate immune signaling in defense against intestinal microbes. Immunol Rev (2012) 245(1):113-31. doi:10.1111/j.1600-065X.2011.01081.x
99. Wang H, Ji Y, Wu G, Sun K, Sun Y, Li W, et al. l-tryptophan activates mammalian target of rapamycin and enhances expression of tight junction proteins in intestinal porcine epithelial cells. J Nutr (2015) 145(6):1156-62. doi:10.3945/jn.114.209817
100. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature (2012) 487(7408):477-81. doi:10.1038/nature11228
101. Ma X, Zhang S, He L, Rong Y, Brier LW, Sun Q, et al. MTORC1-mediated NRBF2 phosphorylation functions as a switch for the class III PtdIns3K and autophagy. Autophagy (2017) 13(3):592-607. doi:10.1080/15548627.2016.1269988
102. Zhang J, Yang G, Wen Y, Liu S, Li C, Yang R, et al. Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide. Mol Nutr Food Res (2017) 61(11):1613-4125. doi:10.1002/mnfr.201700466
103. Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, et al. Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin Cancer Res (2011) 17(1):67-76. doi:10.1158/1078-0432.ccr-10-1763
104. Ferreira SS, Passos CP, Madureira P, Vilanova M, Coimbra MA. Structure-function relationships of immunostimulatory polysaccharides: a review. Carbohydr Polym (2015) 132:378-96. doi:10.1016/j.carbpol.2015.05.079
105. Wu RY, Maattanen P, Napper S, Scruten E, Li B, Koike Y, et al. Non-digestible oligosaccharides directly regulate host kinome to modulate host inflammatory responses without alterations in the gut microbiota. Microbiome (2017) 5(1):135. doi:10.1186/s40168-017-0357-4
106. Shin MS, Hwang SH, Yoon TJ, Kim SH, Shin KS. Polysaccharides from ginseng leaves inhibit tumor metastasis via macrophage and NK cell activation. Int J Biol Macromol (2017) 103:1327-33. doi:10.1016/j.ijbiomac.2017.05.055
107. Bashir KMI, Choi JS. Clinical and physiological perspectives of beta-glucans: the past, present, and future. Int J Mol Sci (2017) 18(9):1906. doi:10.3390/ijms18091906
108. Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-modulated metabolites at the interface of host immunity. J Immunol (2017) 198(2):572-80. doi:10.4049/jimmunol.1601247
109. Shortt C, Hasselwander O, Meynier A, Nauta A, Fernandez EN, Putz P, et al. Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur J Nutr (2017) 1436-6207. doi:10.1007/s00394-017-1546-4
110. Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity (2014) 40(6):833-42. doi:10.1016/j.immuni.2014.05.014
111. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol (2014) 121:91-119. doi:10.1016/B978-0-12-800100-4.00003-9
112. Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med (2016) 22(6):586-97. doi:10.1038/nm.4106
113. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci (2005) 29(3):381-93. doi:10.1016/j.mcn.2005.03.005
114. Hall JA, Cannons JL, Grainger JR, Dos Santos LM, Hand TW, Naik S, et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity (2011) 34(3):435-47. doi:10.1016/j.immuni.2011.03.003
115. Mader D, Rabiet MJ, Boulay F, Peschel A. Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus. Microbes Infect (2010) 12(5):415-9. doi:10.1016/j.micinf.2010.01.014
116. Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature (2014) 511(7508):184-90. doi:10.1038/nature13323
117. Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer (2014) 14(12):801-14. doi:10.1038/nrc3846
118. Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frederick R, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A (2012) 109(7):2497-502. doi:10.1073/pnas.1113873109
119. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ (2002) 9(10):1069-77. doi:10.1038/sj.cdd.4401073
120. Heller JJ, Qiu J, Zhou L. Nuclear receptors take center stage in Th17 cell-mediated autoimmunity. J Clin Invest (2011) 121(2):519-21. doi:10.1172/JCI45939
121. Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A (2010) 107(46):19961-6. doi:10.1073/pnas.1014465107
122. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol (2013) 13(2):145-9. doi:10.1038/nri3365
123. Lanis JM, Alexeev EE, Curtis VF, Kitzenberg DA, Kao DJ, Battista KD, et al. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia. Mucosal Immunol (2017) 10(5):1133-44. doi:10.1038/mi.2016.133
124. Loren V, Cabre E, Ojanguren I, Domenech E, Pedrosa E, Garcia-Jaraquemada A, et al. Interleukin-10 enhances the intestinal epithelial barrier in the presence of corticosteroids through p38 MAPK activity in Caco-2 monolayers: a possible mechanism for steroid responsiveness in ulcerative colitis. PLoS One (2015) 10(6):e0130921. doi:10.1371/journal.pone.0130921
125. Kominsky DJ, Campbell EL, Ehrentraut SF, Wilson KE, Kelly CJ, Glover LE, et al. IFN-gamma-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol (2014) 192(3):1267-76. doi:10.4049/jimmunol.1301757
126. Engelhardt KR, Grimbacher B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol (2014) 380:1-18. doi:10.1007/978-3-662-43492-5_1
127. Mawe GM, Hoffman JM. Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol (2013) 10(8):473-86. doi:10.1038/nrgastro.2013.105
128. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell (2015) 161(2):264-76. doi:10.1016/j.cell.2015.02.047
129. Bhattarai Y, Schmidt BA, Linden DR, Larson ED, Grover M, Beyder A, et al. Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production. Am J Physiol Gastrointest Liver Physiol (2017) 313(1):G80-7. doi:10.1152/ajpgi.00448.2016
130. Brierley SM, Linden DR. Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat Rev Gastroenterol Hepatol (2014) 11(10):611-27. doi:10.1038/nrgastro.2014.103
131. Baganz NL, Blakely RD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci (2013) 4(1):48-63. doi:10.1021/cn300186b
132. Herr N, Bode C, Duerschmied D. The effects of serotonin in immune cells. Front Cardiovasc Med (2017) 4:48. doi:10.3389/fcvm.2017.00048
133. Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res (2012) 27(6):1357-67. doi:10.1002/jbmr.1588
134. Li Q, Zhou JM. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience (2016) 324:131-9. doi:10.1016/j.neuroscience.2016.03.013
135. Roshchina VV. New trends and perspectives in the evolution of neurotransmitters in microbial, plant, and animal cells. Adv Exp Med Biol (2016) 874:25-77. doi:10.1007/978-3-319-20215-0_2
136. Esteban-Zubero E, Lopez-Pingarron L, Alatorre-Jimenez MA, Ochoa-Moneo P, Buisac-Ramon C, Rivas-Jimenez M, et al. Melatonin's role as a co-adjuvant treatment in colonic diseases: a review. Life Sci (2017) 170:72-81. doi:10.1016/j.lfs.2016.11.031
137. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 491(7422):119-24. doi:10.1038/nature11582
138. Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity (2014) 41(2):296-310. doi:10.1016/j.immuni.2014.06.014
139. Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol (2016) 7:979. doi:10.3389/fmicb.2016.00979
140. Kim SH, Cho BH, Kiyono H, Jang YS. Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches. Sci Rep (2017) 7(1):3980. doi:10.1038/s41598-017-02729-6
141. Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 49(5):785-98. doi:10.1007/s00535-014-0953-z
142. Zhang LS, Davies SS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med (2016) 8(1):46. doi:10.1186/s13073-016-0296-x
143. BrestoffJR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol (2013) 14(7):676-84. doi:10.1038/ni.2640
144. Thakur BK, Dasgupta N, Ta A, Das S. Physiological TLR5 expression in the intestine is regulated by differential DNA binding of Sp1/Sp3 through simultaneous Sp1 dephosphorylation and Sp3 phosphorylation by two different PKC isoforms. Nucleic Acids Res (2016) 44(12):5658-72. doi:10.1093/nar/gkw189
145. Nastasi C, Fredholm S, Willerslev-Olsen A, Hansen M, Bonefeld CM, Geisler C, et al. Butyrate and propionate inhibit antigen-specific CD8(+) T cell activation by suppressing IL-12 production by antigen-presenting cells. Sci Rep (2017) 7(1):14516. doi:10.1038/s41598-017-15099-w
146. Wu W, Sun M, Chen F, Cao AT, Liu H, Zhao Y, et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol (2017) 10(4):946-56. doi:10.1038/mi.2016.114
147. Kim M, Qie Y, Park J, Kim CH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe (2016) 20(2):202-14. doi:10.1016/j.chom.2016.07.001
148. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 504(7480):446-50. doi:10.1038/nature12721
149. Kespohl M, Vachharajani N, Luu M, Harb H, Pautz S, WolffS, et al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front Immunol (2017) 8:1036. doi:10.3389/fimmu.2017.01036
150. Tan J, McKenzie C, Vuillermin PJ, Goverse G, Vinuesa CG, Mebius RE, et al. Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways. Cell Rep (2016) 15(12):2809-24. doi:10.1016/j.celrep.2016.05.047